Cargando…
Quantitative immunohistochemical expression of c Kit in breast carcinomas is predictive of patients' outcome
BACKGROUND: c Kit (CD117) expression in tissues has been reported as a relevant target for specific therapy in some human malignancies, but has been poorly documented in breast carcinomas METHODS: The prognostic significance of c Kit in a series of 924 breast carcinomas (mean follow-up, 79 months) w...
Autores principales: | Charpin, C, Giusiano, S, Charfi, S, Secq, V, Carpentier, S, Andrac, L, Lavaut, M-N, Allasia, C, Bonnier, P, Garcia, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713691/ https://www.ncbi.nlm.nih.gov/pubmed/19513067 http://dx.doi.org/10.1038/sj.bjc.6605113 |
Ejemplares similares
-
c-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients' overall and disease-free survival.
por: Charpin, C., et al.
Publicado: (1997) -
Automated and quantitative immunocytochemical assays of Bcl-2 protein in breast carcinomas.
por: Charpin, C., et al.
Publicado: (1997) -
Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905)
por: Dales, J P, et al.
Publicado: (2004) -
c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays
por: Garcia, S, et al.
Publicado: (2007) -
VLA2 integrin expression in breast carcinomas evaluated by automated and quantitative immunohistochemistry.
por: Charpin, C., et al.
Publicado: (1998)